source
- TwoStep Therapeutics raises $62.5 million Series A backed by Pfizer and Merck KGaA venture groupsTwoStep Therapeutics, a cancer biotech, announced a $62.5 million Series A financing to advance its novel approach to antibody-drug conjugates and radioligand therapies. The round was supported by…
- Kura Oncology spins out diabetes program into new company with $50M funding and Lilly supportKura Oncology, known for its leukemia menin inhibitor Komzifti, announced it is separating its diabetes research into a newly formed company. The new entity will receive $50 million in financing,…